Clinical Implication of Candida Score in Multidrug-Resistant Pneumonia with Airway Candida Colonization

다국어 초록 (Multilingual Abstract)

Background The growth of Candida in respiratory secretions is usually considered colonization, and antifungal therapy is rarely required. The role of Candida colonization in the progression of bacterial pneumonia remains controversial. The aim of this study was to identify the clinical implication of Candida score by analyzinge the relationship with multidrug-resistant (MDR) pneumonia and prognosis in patients with airway Candida colonization.




Materials and Methods This study was a retrospective review of patients with airway Candida colonization by bronchial washing or bronchoalveolar lavage. The Candida score was calculated according to the four factors (severe sepsis, surgery at baseline, total parenteral nutrition, and multifocal Candida colonization). Pneumonia related mortality or hopeless discharge expecting death was defined as a poor outcome.




Results A total of 148 patients were enrolled in the study. In a multivariate analysis model, Candida score was identified as an independent predictor of poor outcomes (odds ratio 2.23; 95% confidential interval 1.57 – 3.17; P <0.001) in pneumonia patients with airway Candida colonization. With a Candida score of three or higher compared with low score group, it was associated with bacterial pneumonia, especially methicillin-resistant Staphylococcus aureus (MRSA) infection (0.0% vs. 15.2%, P = 0.004). In addition, patients with a high Candida score had a longer hospital stay (13 vs. 38 days, P <0.001), longer duration of intensive care (7 vs. 18 days, P <0.001), and higher pneumonia-related mortality (0.0% vs. 45.5%, P <0.001) as compared to the low Candida score group. The Candida score showed a positive correlation with other pneumonia severity scales such as CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 years) (r = 0.461, P <0.001), Pneumonia Severity Index (r = 0.397, P <0.001), and predisposition, insult, response, and organ dysfunction (PIRO) score (r = 0.425, P <0.001).




Conclusion This study revealed that Candida is no longer a bystander of airway colonization, and that it affects the progression of bacterial pneumonia, including multidrug-resistant pathogens, particularly MRSA infection. Also Candida score can be used to predict the prognosis of patients with pneumonia.

다국어 초록 (Multilingual Abstract)

Background The growth of Candida in respiratory secretions is usually considered colonization, and antifungal therapy is rarely required. The role of Candida colonization in the progression of bacterial pneumonia remains controversial. The aim of this study was to identify the clinical implication of Candida score by analyzinge the relationship with multidrug-resistant (MDR) pneumonia and prognosis in patients with airway Candida colonization.


Materials and Methods This study was a retrospective review of patients with airway Candida colonization by bronchial washing or bronchoalveolar lavage. The Candida score was calculated according to the four factors (severe sepsis, surgery at baseline, total parenteral nutrition, and multifocal Candida colonization). Pneumonia related mortality or hopeless discharge expecting death was defined as a poor outcome.


Results A total of 148 patients were enrolled in the study. In a multivariate analysis model, Candida score was identified as an independent predictor of poor outcomes (odds ratio 2.23; 95% confidential interval 1.57 – 3.17; P <0.001) in pneumonia patients with airway Candida colonization. With a Candida score of three or higher compared with low score group, it was associated with bacterial pneumonia, especially methicillin-resistant Staphylococcus aureus (MRSA) infection (0.0% vs. 15.2%, P = 0.004). In addition, patients with a high Candida score had a longer hospital stay (13 vs. 38 days, P <0.001), longer duration of intensive care (7 vs. 18 days, P <0.001), and higher pneumonia-related mortality (0.0% vs. 45.5%, P <0.001) as compared to the low Candida score group. The Candida score showed a positive correlation with other pneumonia severity scales such as CURB-65 (Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 years) (r = 0.461, P <0.001), Pneumonia Severity Index (r = 0.397, P <0.001), and predisposition, insult, response, and organ dysfunction (PIRO) score (r = 0.425, P <0.001).


Conclusion This study revealed that Candida is no longer a bystander of airway colonization, and that it affects the progression of bacterial pneumonia, including multidrug-resistant pathogens, particularly MRSA infection. Also Candida score can be used to predict the prognosis of patients with pneumonia.

참고문헌 (Reference)

1 Chastre J, "Ventilator-associated pneumonia" 165 : 867-903, 2002

2 León C, "Usefulness of the"Candida score"for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients : a prospective multicenter study" 37 : 1624-1633, 2009

3 Lisboa T, "The ventilator-associated pneumonia PIRO score : a tool for predicting ICU mortality and health-care resources use in ventilatorassociated pneumonia" 134 : 1208-1216, 2008

4 Aujesky D, "The pneumonia severity index : a decade after the initial derivation and validation" 47 (47): S133-S139, 2008

5 Peters BM, "Staphylococcus aureus adherence to Candida albicans hyphae is mediated by the hyphal adhesin Als3p" 158 : 2975-2986, 2012

6 el-Ebiary M, "Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study" 156 : 583-590, 1997

7 Meersseman W, "Significance of the isolation of Candida species from airway samples in critically ill patients : a prospective, autopsy study" 35 : 1526-1531, 2009

8 Knox KS, "Role of bronchoalveolar lavage diagnostics in fungal infections" 30 : 355-365, 2009

9 Pendleton KM, "Respiratory tract colonization by Candida species portends worse outcomes in immunocompromised patients" 25 : 197-201, 2018

10 Clinical and Laboratory Standards Institute (CLSI), "Performance standards for antimicrobial susceptibility testing. 31st ed" CLSI 2021

11 Rello J, "PIRO score for community-acquired pneumonia : a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia" 37 : 456-462, 2009

12 Markowicz P, "Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors" 161 : 1942-1948, 2000

13 Peleg AY, "Medically important bacterial-fungal interactions" 8 : 340-349, 2010

14 Kalil AC, "Management of adults with hospital-acquired and ventilator-associated pneumonia : 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society" 63 : e61-e111, 2016

15 Bouadma L, "Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit" 51 : 1115-1122, 2010

16 Timsit JF, "Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU : the FUNGIBACT prospective cohort study" 45 : 834-843, 2019

17 Terraneo S, "Impact of Candida spp. isolation in the respiratory tract in patients with intensive care unit-acquired pneumonia" 22 : 94-, 2016

18 Delisle MS, "Impact of Candida species on clinical outcomes in patients with suspected ventilator-associated pneumonia" 18 : 131-136, 2011

19 Leroy G, "Evaluation of"Candida score"in critically ill patients : a prospective, multicenter, observational, cohort study" 1 : 50-, 2011

20 Carlson E, "Enhancement by Candida albicans of Staphylococcus aureus, Serratia marcescens, and Streptococcus faecalis in the establishment of infection in mice" 39 : 193-197, 1983

21 Rello J, "Demographics, guidelines, and clinical experience in severe community-acquired pneumonia" 12 (12): S2-, 2008

22 Pappas PG, "Clinical practice guideline for the management of candidiasis : 2016 update by the Infectious Diseases Society of America" 62 : e1-50, 2016

23 Hamet M, "Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia" 38 : 1272-1279, 2012

24 Tan X, "Candida spp. airway colonization : a potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia" 54 : 557-566, 2016

25 Azoulay E, "Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia" 129 : 110-117, 2006

26 Eggimann P, "Candida colonization index and subsequent infection in critically ill surgical patients : 20 years later" 40 : 1429-1448, 2014

27 Ricard JD, "Candida colonization in ventilated ICU patients: no longer a bystander!" 38 : 1243-1245, 2012

28 Harriott MM, "Candida albicans and Staphylococcus aureus form polymicrobial biofilms : effects on antimicrobial resistance" 53 : 3914-3922, 2009

29 Jones BE, "CURB-65 pneumonia severity assessment adapted for electronic decision support" 140 : 156-163, 2011

30 Corrado RE, "Burden of adult community-acquired, health-careassociated, hospital-acquired, and ventilator-associated pneumonia : New York City, 2010 to 2014" 152 : 930-942, 2017

31 Frey-Klett P, "Bacterial-fungal interactions : hyphens between agricultural, clinical, environmental, and food microbiologists" 75 : 583-609, 2011

32 Lindau S, "Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects" 3 : 31-, 2015

33 Roux D, "Airway fungal colonization compromises the immune system allowing bacterial pneumonia to prevail" 41 : e191-e199, 2013

34 Harriott MM, "Ability of Candida albicans mutants to induce Staphylococcus aureus vancomycin resistance during polymicrobial biofilm formation" 54 : 3746-3755, 2010